← Leaderboards
Samuel E Lynch
Biomimetic Pharmaceuticals, Inc.
$358,851
Attributed
$358,851
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$358,851 · 2
By mechanism
R43$358,851 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Biomarker”
- David R. Weir · University Of Michigan At Ann Arbor$368,126,077
- Leonard Freedman · Leidos Biomedical Research, Inc.$248,231,562
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$217,859,034
- Ralph Parchment · Leidos Biomedical Research, Inc.$186,322,680
- Randall J Bateman · Washington University$182,177,358
- Paul S. Aisen · Cognition Therapeutics, Inc.$182,141,353
Research focus
BiomarkerBiomaterial Development /PreparationBiomaterial EvaluationBone Metabolism DisorderBone RegenerationCell AdhesionCell ProliferationClinical ResearchCollagenDental AlveolusDental ResearchDiagnostic TestsDogsGingivaHuman SubjectImmunologic Assay /TestOsteogenesisPathologic Bone ResorptionPeriodontitisPeriodontiumPlatelet Derived Growth FactorPolymersPreventive DentistryTechnology /Technique Development